These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17999838)

  • 21. Comparison of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution and artificial tears in seasonal allergic conjunctivitis.
    Kamis U; Ozturk BT; Ozkagnici A; Gunduz K
    Acta Ophthalmol Scand; 2006 Feb; 84(1):148-9. PubMed ID: 16445458
    [No Abstract]   [Full Text] [Related]  

  • 22. Mast cell stabilizers for the relief of allergic conjunctivitis.
    Bataoel A
    Insight; 2007; 32(1):25. PubMed ID: 17533783
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy of once-daily olopatadine 0.2% ophthalmic solution compared to twice-daily olopatadine 0.1% ophthalmic solution for the treatment of ocular itching induced by conjunctival allergen challenge.
    Abelson MB; Spangler DL; Epstein AB; Mah FS; Crampton HJ
    Curr Eye Res; 2007 Dec; 32(12):1017-22. PubMed ID: 18085465
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Opatanol].
    Johansen S
    Ugeskr Laeger; 2003 Jul; 165(30):2957. PubMed ID: 12926197
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of eye rubbing on signs and symptoms of allergic conjunctivitis in cat-sensitive individuals.
    Raizman MB; Rothman JS; Maroun F; Rand WM
    Ophthalmology; 2000 Dec; 107(12):2158-61. PubMed ID: 11097588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Allergic conjunctivitis; primary and secondary role of the allergic reaction in the nose].
    Pelikan Z
    Ned Tijdschr Geneeskd; 1988 Mar; 132(13):561-3. PubMed ID: 3362222
    [No Abstract]   [Full Text] [Related]  

  • 27. [Conjunctivitis and contact allergy].
    Bonneau JC
    Allerg Immunol (Paris); 1993 Mar; 25(3):112-4, 117-8. PubMed ID: 8318141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allergic conjunctivitis.
    Bonini S; Lambiase A; Juhas T; Bonini S
    Dev Ophthalmol; 1999; 30():54-61. PubMed ID: 10627916
    [No Abstract]   [Full Text] [Related]  

  • 29. [Polish agreement in ocular allergy diagnostics and treatment].
    Bogacka E; Górski P; Groblewska A; Misiuk-Hojło M; Jedrzejczak-Czechowicz M; Pałczynski C; Zaleska-Zmijewska A; Kune P; Szaflika J; ; ; ;
    Klin Oczna; 2008; 110(4-6):219-26. PubMed ID: 18655466
    [No Abstract]   [Full Text] [Related]  

  • 30. [Occupational allergic conjunctivitis].
    Wittczak T; Pas-Wyroilak A; Pałczyński C
    Med Pr; 2007; 58(2):125-30. PubMed ID: 17926501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The conjunctival flora in vernal conjunctivitis patients.
    Gündüz A; Gündüz A; Cumurcu T; Doganay V; Seyrek A
    Ann Ophthalmol (Skokie); 2009; 41(2):98-101. PubMed ID: 19845225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Conjunctivitis, keratitis, keratoconjunctivitis: role of allergy].
    Wessel F
    Allerg Immunol (Paris); 1996 Mar; 28(3):74-6, 79-80. PubMed ID: 8703312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ocular allergic disorders and dry eye disease: associations, diagnostic dilemmas, and management.
    Berdy GJ; Hedqvist B
    Acta Ophthalmol Scand Suppl; 2000; (230):32-7. PubMed ID: 11057347
    [No Abstract]   [Full Text] [Related]  

  • 34. Adverse reactions to the allergen conjunctival provocation test.
    Mourão EM; Rosário NA
    Ann Allergy Asthma Immunol; 2011 Oct; 107(4):373-4. PubMed ID: 21962101
    [No Abstract]   [Full Text] [Related]  

  • 35. Allergic conjunctivitis.
    Bielory L; Friedlaender MH
    Immunol Allergy Clin North Am; 2008 Feb; 28(1):43-58, vi. PubMed ID: 18282545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A simple and rapid diagnostic algorithm for the detection of ocular allergic diseases.
    Mantelli F; Lambiase A; Bonini S
    Curr Opin Allergy Clin Immunol; 2009 Oct; 9(5):471-6. PubMed ID: 19638928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of olopatadine HCI 0.1%, ketotifen fumarate 0.025%, epinastine HCI 0.05%, emedastine 0.05% and fluorometholone acetate 0.1% ophthalmic solutions for seasonal allergic conjunctivitis: a placebo-controlled environmental trial.
    Borazan M; Karalezli A; Akova YA; Akman A; Kiyici H; Erbek SS
    Acta Ophthalmol; 2009 Aug; 87(5):549-54. PubMed ID: 18631332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seasonal sensorineural hearing loss associated with allergic rhinitis: a case report.
    Lombardi C; Tansini A; Passalacqua G
    J Allergy Clin Immunol; 2006 Feb; 117(2):468-9. PubMed ID: 16461152
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug approvals: '08 in review. Olopatadine hydrochloride (Patanase) nasal spray.
    Laustsen G; Carrillo F; Johnson J; Smith C
    Nurse Pract; 2009 Feb; 34(2):29. PubMed ID: 19155880
    [No Abstract]   [Full Text] [Related]  

  • 40. Drugs for allergic disorders.
    Treat Guidel Med Lett; 2003 Nov; 1(15):93-100. PubMed ID: 15529098
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.